Even so, the clinical treatment plan and prognosis judgment are made according to the TNM grade of the tumor, the clinical stage of the tumor, the level of hormone expression, and the expression level of HER2 because of the lack of reliable prognostic biomarkers. Here, ERBB2 is linked to neoplasm.